We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Three-Dimensional Growth Chamber Promotes Understanding of Angiogenesis

By LabMedica International staff writers
Posted on 11 Feb 2019
Print article
Image: The microvessel-on-a-chip used for angiogenesis research (Photo courtesy of Dr. Yukiko Matsunaga, Institute of Industrial Science, the University of Tokyo).
Image: The microvessel-on-a-chip used for angiogenesis research (Photo courtesy of Dr. Yukiko Matsunaga, Institute of Industrial Science, the University of Tokyo).
Collaboration between French and Japanese researchers resulted in the development of a three-dimensional "microvessel-on-a-chip" device for advancing the understanding of the processes that drive angiogenesis (production of new blood vessels).

Elucidating the mechanisms underlying sprouting angiogenesis and permeability should enable the development of more effective therapies for various diseases, including retinopathy, cancer, and other vascular disorders. Sprouting angiogenesis was the first identified form of angiogenesis. It occurs in several well-characterized stages. First, biological signals known as angiogenic growth factors activate receptors on endothelial cells present in pre-existing blood vessels. Second, the activated endothelial cells begin to release proteases that degrade the basement membrane to allow endothelial cells to escape from the original (parent) vessel walls.

The endothelial cells then proliferate into the surrounding matrix and form solid sprouts connecting neighboring vessels. As sprouts extend toward the source of the angiogenic stimulus, endothelial cells migrate in tandem, using adhesion molecules called integrins. These sprouts then form loops to become a full-fledged vessel lumen as cells migrate to the site of angiogenesis. Sprouting occurs at a rate of several millimeters per day, and enables new vessels to grow across gaps in the vasculature.

Investigators at the Institute of Industrial Science of the University of Tokyo (Japan) and the French National Center for Scientific Research (Lille, France) focused on the protein EGFL7 (epidermal growth factor-like domain 7), which plays an important role in NOTCH signaling and in the organization of angiogenic sprouts. For this purpose they developed a three-dimensional EGFL7-knockdown in vitro microvessel model in order to investigate the effect of EGFL7 at a tissue level.

The investigators reported in the March 2019 online edition of the journal Biomaterials that EGFL7 knockdown suppressed vascular endothelial growth factor A (VEGF-A)-induced sprouting angiogenesis accompanied by an overproduction of endothelial filopodia and reduced collagen IV deposition at the basal side of endothelial cells. They also observed impaired barrier function, which reflected an inflammatory condition. Furthermore, the results showed that proper formation of adherens junctions and phosphorylation of VE-cadherin was disturbed.

"We obtained more insight into how blood vessels form by building our own in the lab from scratch, first forming a collagen mold containing a needle that was then removed, leaving a space that was then colonized by human umbilical vein endothelial cells," said senior author Dr. Yukiko T. Matsunaga, associate professor of biomedical engineering at the University of Tokyo. "We next examined the effects of EGFL7 by comparing two models of this type, one in which this molecule was allowed to function normally in these cells and another in which it was knocked down by siRNA."

Related Links:
Institute of Industrial Science of the University of Tokyo
French National Center for Scientific Research

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
HLX
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The study showed the blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% (Photo courtesy of Guardant Health)

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer

Colorectal cancer is the second biggest cause of cancer deaths among adults in the U.S., with forecasts suggesting 53,010 people might die from it in 2024. While fewer older adults are dying from this... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Microbiology

view channel
Image: The new platform is designed to perform blood-based diagnoses of nontuberculosis mycobacteria (Photo courtesy of 123RF)

New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours

Breathing in nontuberculous mycobacteria (NTM) is a common experience for many people. These bacteria are present in water systems, soil, and dust all over the world and usually don't cause any problems.... Read more

Industry

view channel
Image: These new assays are being developed for use on the recently introduced DxI 9000 Immunoassay Analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics

Beckman Coulter Diagnostics (Brea, CA, USA) and Fujirebio Diagnostics (Tokyo, Japan) have expanded their partnership focused on the development, manufacturing and clinical adoption of neurodegenerative... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.